91
77
Growth Score
25 pts
Heat Score
75 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
222199
BrainStorm Therapeutics models CNS disorders via organoids and AI.
- Maya Gosztyla: CSO & Co-Founder
- Robert Fremeau: Founder & CEO
About the Company
BrainStorm Therapeutics is a private research and development firm that builds high-throughput human brain organoid systems to model central nervous system disorders. The company integrates these human-derived cellular models with computational platforms to map disease biology and accelerate therapeutic target discovery for neurodegenerative
diseases and rare epilepsies.
